Health, Fitness & Food

Thomas Kurian, CEO of Alphabet’s Google Cloud, speaks at the Google Cloud Next conference in San Francisco on April 9, 2019. Michael Short | Bloomberg | Getty Images Account reps from Epic Systems, one of the largest providers of medical record systems, have started calling customers with a clear message: We will not be pursuing
0 Comments
Jen Horonjeff, a patient with an auto-immune disease, wore a hospital gown on stage during her panel at the J.P. Morgan Healthcare Conference in Jan. 2020 to remind attendees to focus on patients. Thousands of health executives descended on San Francisco this week for the annual J.P. Morgan Healthcare Conference to pitch their companies, forge
0 Comments
David Katzman, CEO of SmileDirectClub stands with founders Jordan Katzman and Alex Fenkell as the company debuts its IPO at the Nasdaq MarketSite in New York, September 12, 2019. Lucas Jackson | Reuters SmileDirectClub stock rose 15% on Monday after it announced that it will start selling its teeth-straightening products to dentists and orthodontists. The
0 Comments
A technician at the Novartis Institutes for BioMedical Research in Cambridge, Massachusetts. David L. Ryan | The Boston Globe | Getty Images Pharmaceutical giant Novartis has reached a deal with the U.K. government to provide its late-stage cholesterol drug, inclisiran, to patients at high risk of a heart attack, the company announced Monday. The drug,
0 Comments
Anne Viola-Krase, a Virta Health patient Anne Viola-Krause Anne Viola-Krause has been taking medication for her diabetes for more than a decade. In 2016, her doctor recommended that she up her dose, but Viola-Krause felt reluctant because of the side effects. Viola-Krause is one of more than 30 million Americans with type 2 diabetes, which
0 Comments
Raj Singh, chief executive officer of Accolade speaks during the GeekWire Summit event in Seattle, Washington, Oct. 3, 2018. David Ryder | Bloomberg | Getty Images Accolade, a start-up that helps workers navigate their health benefits and dealings with insurance companies, has hired banks including Goldman Sachs and Morgan Stanley to advise ahead of a
0 Comments
Amir Rubin, new CEO of One Medical One Medical One Medical, a chain of primary care clinics that touts a “technology-powered model” and has raised money from Alphabet, just filed to go public on the Nasdaq.  Founded in 2007, One Medical provides care at facilities in nine metropolitan markets throughout the country, with three more on
0 Comments
Chris Ratcliffe | Bloomberg | Getty Images The Food and Drug Administration would consider restricting the sale of menthol-flavored vaping products if teens start using them as the agency moves to ban most other flavors, an FDA official said Friday. Mitch Zeller, director of the FDA’s Center for Tobacco Products, told CNBC’s “Squawk Box” that
0 Comments
A woman undergoes a mammogram exam. Media for Medical | Getty Images Artificial Intelligence (AI) powered by Google’s DeepMind algorithm may be more accurate at spotting breast cancer than real life doctors. The findings, published in Nature.com on Wednesday, come after researchers from Imperial College London and Google Health “trained” a computer to spot abnormalities
0 Comments
Getty Images When it came to biomedical breakthroughs, this past decade represented a lot more hype than substance. We were promised a new era of “precision medicine,” where every patient would receive highly personalized treatments to target specifics fault in their genes. But in recent months, reports surfaced that these experimental therapies were failing most
0 Comments
Former Food and Drug Administration Commissioner Scott Gottleib testifies before the House Agriculture, Rural Development, Food and Drug Administration and Related Agencies Subcommittee about the Trump Administration’s proposed federal budget during a hearing in the Rayburn House Office Building on Capitol Hill May 25, 2017 in Washington, DC. Chip Somodevilla / Getty Images The Food
0 Comments
Alex Raths | Getty Images Biotechnology was one of the decade’s best investments as a dizzying pace of clinical innovation fueled the discovery of treatments once thought beyond the reach of modern medicine. A more aggressive FDA also aided the trend. An investor who purchased shares of the iShares Nasdaq Biotechnology ETF in December 2009
0 Comments